chr14-102445813-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014844.5(TECPR2):​c.2941C>A​(p.Gln981Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0193 in 1,613,582 control chromosomes in the GnomAD database, including 361 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 24 hom., cov: 31)
Exomes 𝑓: 0.020 ( 337 hom. )

Consequence

TECPR2
NM_014844.5 missense

Scores

4
5
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.71

Publications

12 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006488502).
BP6
Variant 14-102445813-C-A is Benign according to our data. Variant chr14-102445813-C-A is described in ClinVar as Benign. ClinVar VariationId is 240924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2159/152076) while in subpopulation NFE AF = 0.0211 (1433/68000). AF 95% confidence interval is 0.0202. There are 24 homozygotes in GnomAd4. There are 1027 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014844.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECPR2
NM_014844.5
MANE Select
c.2941C>Ap.Gln981Lys
missense
Exon 13 of 20NP_055659.2O15040-1
TECPR2
NM_001172631.3
c.2941C>Ap.Gln981Lys
missense
Exon 13 of 17NP_001166102.1O15040-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECPR2
ENST00000359520.12
TSL:1 MANE Select
c.2941C>Ap.Gln981Lys
missense
Exon 13 of 20ENSP00000352510.7O15040-1
TECPR2
ENST00000558678.1
TSL:1
c.2941C>Ap.Gln981Lys
missense
Exon 13 of 17ENSP00000453671.1O15040-2
TECPR2
ENST00000856897.1
c.2941C>Ap.Gln981Lys
missense
Exon 13 of 20ENSP00000526956.1

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2158
AN:
151958
Hom.:
24
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00435
Gnomad AMI
AF:
0.0795
Gnomad AMR
AF:
0.00729
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0185
Gnomad FIN
AF:
0.0142
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0211
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0172
AC:
4327
AN:
251142
AF XY:
0.0184
show subpopulations
Gnomad AFR exome
AF:
0.00449
Gnomad AMR exome
AF:
0.00612
Gnomad ASJ exome
AF:
0.0283
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0142
Gnomad NFE exome
AF:
0.0234
Gnomad OTH exome
AF:
0.0193
GnomAD4 exome
AF:
0.0199
AC:
29031
AN:
1461506
Hom.:
337
Cov.:
31
AF XY:
0.0200
AC XY:
14566
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.00523
AC:
175
AN:
33468
American (AMR)
AF:
0.00687
AC:
307
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
768
AN:
26120
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39686
South Asian (SAS)
AF:
0.0217
AC:
1868
AN:
86234
European-Finnish (FIN)
AF:
0.0135
AC:
721
AN:
53410
Middle Eastern (MID)
AF:
0.0297
AC:
171
AN:
5760
European-Non Finnish (NFE)
AF:
0.0215
AC:
23953
AN:
1111768
Other (OTH)
AF:
0.0176
AC:
1060
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1498
2995
4493
5990
7488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2159
AN:
152076
Hom.:
24
Cov.:
31
AF XY:
0.0138
AC XY:
1027
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.00439
AC:
182
AN:
41476
American (AMR)
AF:
0.00728
AC:
111
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5166
South Asian (SAS)
AF:
0.0183
AC:
88
AN:
4812
European-Finnish (FIN)
AF:
0.0142
AC:
150
AN:
10580
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0211
AC:
1433
AN:
68000
Other (OTH)
AF:
0.0132
AC:
28
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
106
211
317
422
528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0196
Hom.:
131
Bravo
AF:
0.0136
TwinsUK
AF:
0.0227
AC:
84
ALSPAC
AF:
0.0249
AC:
96
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.0221
AC:
190
ExAC
AF:
0.0183
AC:
2219
Asia WGS
AF:
0.00982
AC:
35
AN:
3478
EpiCase
AF:
0.0199
EpiControl
AF:
0.0221

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Hereditary spastic paraplegia 49 (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.036
T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.0065
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
2.9
M
PhyloP100
7.7
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-2.2
N
REVEL
Benign
0.24
Sift
Benign
0.047
D
Sift4G
Uncertain
0.022
D
Polyphen
1.0
D
Vest4
0.21
MPC
0.57
ClinPred
0.036
T
GERP RS
5.3
Varity_R
0.36
gMVP
0.78
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62000389; hg19: chr14-102912150; COSMIC: COSV63970627; COSMIC: COSV63970627; API